Karin Rosen
Chief Tech/Sci/R&D Officer en HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY .
Cargos activos de Karin Rosen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 02/11/2020 | - |
| DIAMYD MEDICAL AB | Director/Board Member | 10/03/2023 | - |
Historial de carrera de Karin Rosen
Antiguos cargos conocidos de Karin Rosen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/11/2018 | 01/11/2020 |
Formación de Karin Rosen.
| University of Lund | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 3 |
| Irlanda | 2 |
| Reino Unido | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GSK PLC | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Karin Rosen
- Experiencia
